Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic thrombophilia.

W Gregory Feero1

  • 1Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH, 03755, USA. gfeero@mainegeneral.org

Primary Care
|August 28, 2004
PubMed
Summary
This summary is machine-generated.

Genetic thrombophilias increase the risk of venous thrombotic events. This review covers factor V Leiden, prothrombin G20210A, and deficiencies in protein C, protein S, and antithrombin, including testing and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic counselors' perspectives and experiences with workplace genetic testing: Results of a national survey.

Genetics in medicine open·2026
Same author

Multidisciplinary stakeholder-informed identification of key characteristics for implementation of workplace genetic testing.

HGG advances·2025
Same author

Workplace perk or pitfall? A qualitative study of genetic counselors' perspectives and experiences with workplace genetic testing.

Journal of genetic counseling·2025
Same author

Guidance on Use of Race, Ethnicity, and Geographic Origin as Proxies for Genetic Ancestry Groups in Biomedical Publications.

Genetics in medicine : official journal of the American College of Medical Genetics·2024
Same author

Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications.

Nature genetics·2024
Same author

Guidance on use of race, ethnicity, and geographic origin as proxies for genetic ancestry groups in biomedical publications.

HGG advances·2024
Same journal

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026
Same journal

We Care, and We Will Listen.

Primary care·2026
Same journal

Addressing Sexual Health in Primary Care.

Primary care·2026
Same journal

Diagnosis and Management of Eating Disorders in Adolescents and Young Adults.

Primary care·2026
Same journal

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment.

Primary care·2026
Same journal

Nonpharmacologic Management of Insomnia Disorder in Primary Care.

Primary care·2026
See all related articles

Area of Science:

  • Genetics
  • Hematology
  • Medical Science

Background:

  • Genetic thrombophilias are significant risk factors for venous thrombotic events (VTE).
  • Understanding the natural history and genetic basis of these disorders is crucial for effective management.
  • Existing knowledge on treatment for genetic thrombophilias is developing.

Purpose of the Study:

  • To provide a comprehensive overview of the genetics of thrombophilia.
  • To review specific genetic mutations and deficiencies associated with increased thrombosis risk.
  • To discuss current diagnostic and therapeutic strategies for inherited thrombophilias.

Main Methods:

  • Literature review focusing on genetic thrombophilias.
  • Synthesis of information on specific genetic factors: Factor V Leiden, Prothrombin G20210A.

Related Experiment Videos

  • Review of deficiencies in anticoagulant proteins: Protein C, Protein S, Antithrombin.

    • Main Results:

    • Factor V Leiden and Prothrombin G20210A are common genetic risk factors for VTE.
    • Deficiencies in Protein C, Protein S, and Antithrombin significantly elevate thrombosis risk.
    • Genetic testing and various treatment options are available for managing these conditions.

    Conclusions:

    • Genetic thrombophilias represent a key area in understanding VTE.
    • Knowledge of specific genetic mutations and deficiencies aids in risk assessment.
    • Current testing and treatment modalities offer pathways for managing patients with inherited thrombophilia.